The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 330:1754-1755 June 16, 1994 Number 24
NextNext

Clostridium difficile Colitis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Kelly, C. P.
To the Editor: The review of Clostridium difficile colitis (Jan. 27 issue)1 contains the misleading statement that "the laboratory diagnosis of C. difficile infection depends on the demonstration of C. difficile toxins in stool" by the stool-cytotoxin assay, which has a "high sensitivity (94 to 100 percent) and specificity (99 percent)." The studies cited to support this statement required a positive cytotoxin assay for their definition of a true positive case. Therefore, these studies cannot define the sensitivity of the cytotoxin test for the diagnosis of C. difficile-associated disease.

Mcfarland et al. found the cytotoxin assay to be neither completely . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.